Advanced search
Publication Cover
Biotechnology & Biotechnological Equipment Volume 37, 2023 - Issue 1
Submit an article Journal homepage
264
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Analyzing real-world data to understand COVID-19 vaccination effects on hospitalization rates in patients with solid malignancies

George Dimitrova Department of Medical Oncology, Medical University of Sofia, University Hospital “Tsaritsa Yoanna”, Sofia, BulgariaCorrespondence[email protected]
View further author information
,
Radka Argirovab Department of Clinical Laboratory, Acibadem City Clinic Tokuda Hospital, Sofia, BulgariaView further author information
&
Trifon Valkovc Department of Infectious Diseases, Medical University of Sofia, Prof. Ivan Kirov Hospital, Sofia, BulgariaView further author information
Article: 2282141 | Received 26 Sep 2023, Accepted 07 Nov 2023, Published online: 19 Nov 2023

References

  • Khoury E, Nevitt S, Madsen WR, et al. Differences in outcomes and factors associated with mortality among patients with SARS-CoV-2 infection and cancer compared with those without cancer: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(5):1. doi: 10.1001/jamanetworkopen.2022.10880.
  • Chavez-MacGregor M, Lei X, Zhao H, et al. Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer. JAMA Oncol. 2022;8(1):69–6. doi: 10.1001/jamaoncol.2021.5148.
  • Horn L, Whisenant JG, Torri V, et al. Thoracic cancers international COVID-19 collaboration (TERAVOLT): impact of type of cancer therapy and COVID therapy on survival. J Clin Oncol. 2020;38(18_suppl):LBA111–LBA111. doi: 10.1200/JCO.2020.38.18_suppl.LBA111.
  • Manzano J-GM, Muthu M, Kheder E, et al. Hospitalization characteristics and outcomes of patients with cancer and COVID-19 at a comprehensive cancer center. Support Care Cancer. 2022;30(9):7783–7788. doi: 10.1007/s00520-022-07209-w.
  • Wu Q, Luo S, Xie X. The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants. BMC Cancer. 2022;22(1):241. doi: 10.1186/s12885-022-09320-x.
  • Sengar M, Chinnaswamy G, Ranganathan P, et al. Outcomes of COVID-19 and risk factors in patients with cancer. Nat Cancer. 2022;3(5):547–551. doi: 10.1038/s43018-022-00363-4.
  • Aboueshia M, Hussein MH, Attia AS, et al. Cancer and COVID-19: analysis of patient outcomes. Future Oncol. 2021;17(26):3499–3510. doi: 10.2217/fon-2021-0121.
  • Ali JK, Riches JC. The impact of the COVID-19 pandemic on oncology care and clinical trials. Cancers. 2021;13(23):5924. doi: 10.3390/cancers13235924.
  • Health BMo. United Informatio Portal 2023. [2023 Feb 09]. Available from: https://coronavirus.bg/.
  • Lei H, Yang Y, Zhou W, et al. Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis. Lung Cancer. 2021;157:60–65. doi: 10.1016/j.lungcan.2021.05.002.
  • Kathuria-Prakash N, Antrim L, Hornstein N, et al. Factors associated with hospitalization among breast cancer patients with COVID-19: a diverse multi-center Los Angeles cohort study. Clin Breast Cancer. 2022;22(4):e558–e66. doi: 10.1016/j.clbc.2021.12.005.
  • Abuhelwa Z, Alsughayer A, Abuhelwa AY, et al. In-hospital mortality and morbidity in cancer patients with COVID-19: a nationwide analysis from the United States. Cancers. 2022;15(1):222. doi: 10.3390/cancers15010222.
  • de Azambuja E, Brandão M, Wildiers H, et al. Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis. ESMO Open. 2020;5(5):e000947. doi: 10.1136/esmoopen-2020-000947.
  • Lee LYW, Cazier JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020;21(10):1309–1316. doi: 10.1016/S1470-2045(20)30442-3.
  • Saini KS, Tagliamento M, Lambertini M, et al. Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies. Eur J Cancer. 2020;139:43–50. doi: 10.1016/j.ejca.2020.08.011.
  • Lee LYW, Starkey T, Ionescu MC, et al. Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study. Lancet Oncol. 2022;23(6):748–757. doi: 10.1016/S1470-2045(22)00202-9.
  • Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J. 2022;19(1):92. doi: 10.1186/s12985-022-01814-1.
  • Monari C, Sagnelli C, Maggi P, et al. More severe COVID-19 in patients with active cancer: results of a multicenter cohort study. Front Oncol. 2021;11:662746. doi: 10.3389/fonc.2021.662746.
  • Lee LY, Cazier JB, Angelis V, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926. doi: 10.1016/S0140-6736(20)31173-9.
  • Shuai H, Chan JF-W, Hu B, et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 omicron. Nature. 2022;603(7902):693–699. doi: 10.1038/s41586-022-04442-5.
  • Chalkias S, Harper C, Vrbicky K, et al. A bivalent omicron-containing booster vaccine against covid-19. N Engl J Med. 2022;387(14):1279–1291. doi: 10.1056/NEJMoa2208343.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.